Interventional cardiologists at NYU Langone’s Transcatheter Heart Valve Program—Long Island use nonsurgical transcatheter approaches that require only a small incision in the leg to treat aortic valve disease and mitral valve disease.
Our cardiac experts perform transcatheter aortic valve replacement (TAVR) to treat aortic valve disease. TAVR is an option for many people who need treatment for aortic valve disease, including those classified as high-risk who for medical reasons would not be a candidate for open heart surgery, as well as people who are considered low-risk for complications due to their relatively young age and overall good health.